Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Cancer Nurs. 2014 Mar-Apr;37(2):E51–E59. doi: 10.1097/NCC.0b013e318283a7bc

Table 2.

Sample Description by Severity of Insomnia in 654 Participants

Patient Characteristics Insomnia Item Scorea
Socio-Demographic Factors Total
N=654 (100%)
High Score (≥4)
n=135 (100%)
Low Score (≤3)
n=519 (100%)
p-valueb
 Gender, male 351 (53.7%) 60 (44.4%) 291 (56.1%) .02
 Age, mean (range) 53.9 (18–89) 53.1 (24–84) 54.0 (18–89) .50
 Ethnicity, Hispanic/Latino 12 (1.8%) 3 (2.2%) 9 (1.7%) .72
 Race, minority or multiplec 48 (7.3%) 15 (11.1%) 33 (6.4%) .06
 Married/partnered 454 (69.4%) 89 (65.9%) 365 (70.3%) .40
 Low income (<35k HH annual) 153 (23.4%) 40 (29.6%) 113 (21.8%) .06
 Some college/college graduate 469 (71.7%) 92 (68.1%) 377 (72.6%) .39
 Frequent computer use 520 (79.5%) 100 (74.1%) 420 (80.9%) .09
Study Group .77
 Control 330 (50.5%) 70 (51.9%) 260 (50.1%)
 Intervention 324 (49.5%) 65 (48.1%) 259 (49.9%)
Clinical Factors
Service line .10
 Medical 304 (46.5%) 55 (40.7%) 249 (48%)
 Radiation 152 (23.2%) 32 (23.7%) 120 (23.1%)
 Transplant 198 (30.3%) 48 (35.6%) 120 (28.9%)
Cancer Diagnosis .26
 Breast 43 (6.6%) 11 (8.1%) 32 (6.2%)
 Gastrointestinal 78 (11.9%) 10 (7.4%) 68 (13.1%)
 Genitourinary 75 (11.5%) 8 (5.9%) 67 (12.9%)
 Gynecological 62 (9.5%) 19 (14.1%) 43 (8.3%0
 Head and Neck 54 (8.3%) 11 (8.1%) 43 (8.3%)
 Leukemia 102 (15.6%) 25 (18.5%) 77 (14.8%)
 Lung 40 (6.1%) 10 (7.45%) 30 (5.8%)
 Lymphoma 103 (15.7%) 18 (13.3%) 85 (16.4%)
 Myeloma 45 (6.9%) 9 (6.7%) 36 (6.9%)
 Other 52 (8.0%) 14 (10.4%) 38 (7.3%)
a

Insomnia item on the Symptom Distress Scale range from 1–5

b

P-value from Fisher’s exact test (t-test for age) for the association between insomnia groups (low vs high) and the given variables at baseline (socio-demographics and clinical factors).

c

Includes anyone who reported race as anything other than “White/Caucasian” and those who reported more than one race.